# Intensive Glycemic Control and Skeletal Health Study

> **NCT00324350** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 7287 (actual)

## Conditions studied

- Atherosclerosis
- Cardiovascular Diseases
- Hypercholesterolemia
- Hypertension
- Diabetes Mellitus
- Coronary Disease

## Interventions

- **DRUG:** hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents

## Key facts

- **NCT ID:** NCT00324350
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 7287 (ACTUAL)
- **Last updated:** 2012-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324350, "Intensive Glycemic Control and Skeletal Health Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00324350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*